ARCHIVES

In Brief: Congress Asked To Investigate Dieldrin Danger; Harvard’s Rosenberg To Be NCI Surgery Chief

This article is from The Cancer Letter archive.

Vol. 01 No. 09 | April 5, 1974

Download PDF Visit The Full Archive

Related Articles

Biotheraputics Inc. Markets ‘Custom Made’ Experimental Therapy

August 9, 1985

NCI To Offer Advice On Unconventional Therapy. Not Funds

December 14, 1990

CCRAC Calls for New Comp Center, Community Hospital Core Grants For Control Development

August 24, 1979

FDA orders “limited distribution” for lung cancer drug Iressa.

June 24, 2005

Phase 1 AIDS Vaccine Trial Will Involve 81 Persons At NIH

August 28, 1987

Genetic Test Identifies Patients With High Risk of Mortality

November 30, 2012